Skip to content
The Nexus
DossierENTITY

pharma investment

Coverage of pharma investment in the Nexus archive.

Earliest in view: Apr 29 · 12:15 UTCMost recent: Apr 29 · 12:15 UTC
Co-mentioned in this coverage
Recent coverage
  • BUSINESSApr 29 · 12:15 UTCTHE GUARDIAN WORLD
    AstraZeneca makes surprise U-turn with £300m pharma investment

    AstraZeneca has reversed its decision to pause large-scale UK projects, pledging a £300m investment in the country after previously citing dissatisfaction with the NHS and drug pricing. The announcement, made by Keir Starmer, marks a surprise shift in the company's stance on the UK business environment.

pharma investment · Dossier · The Nexus